C3B3-DB

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameC3B3-DB

Drug Alias Namerecombinant single-chain Fv anti-HLA-A diabody (Chugai)C3B3-DB

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionHistocompatibility antigens class I modulators

TargetsHistocompatibility antigens class I

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesChugai Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesChugai Pharmaceutical Co Ltd

Active IndicationsN/A

Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A